Jaguar Health (JAGX) Intangibles (2017 - 2026)
Jaguar Health's (JAGX) quarterly Intangibles came in at $11.6 million in Q1 2026, down 12.55% year-on-year from $13.2 million in Q1 2025, and down 27.89% on a QoQ basis from $16.0 million in Q4 2025.
Jaguar Health (JAGX) Intangibles (2017 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 10 years of Intangibles data on file, last reported at $11.6 million in Q1 2026.
- On a quarterly basis, Intangibles fell 12.55% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $11.6 million, a 12.55% decrease from a year earlier, with the FY2025 full-year figure at $16.0 million, down 13.3% from the prior year.
- Intangibles for Q1 2026 stood at $11.6 million, down from $16.0 million in the prior quarter.
- Over the last five years, Intangibles for JAGX reached as high as $23.0 million in Q2 2022 and fell as low as $11.6 million in Q1 2026.
- Historically, Intangibles has averaged $18.1 million across 5 years, with a median of $18.5 million in 2024.
- Across the five-year window, Intangibles gained 17.14% in 2024 and tumbled 34.33% in 2025, its largest moves.
- Year by year, Intangibles stood at $22.4 million in 2022, then decreased by 10.35% to $20.1 million in 2023, then slipped by 8.14% to $18.5 million in 2024, then slipped by 13.3% to $16.0 million in 2025, then slipped by 27.89% to $11.6 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $11.6 million in Q1 2026, $16.0 million in Q4 2025, and $17.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | 11,379.54 |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 30.30 Mn |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 61.68 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 418.50 Mn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 1.29 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 266.00 Mn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | 55.80 Mn |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 11.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.55 Mn |
| Dec 31, 2025 | 16.02 Mn |
| Sep 30, 2025 | 17.29 Mn |
| Jun 30, 2025 | 12.75 Mn |
| Mar 31, 2025 | 13.21 Mn |
| Dec 31, 2024 | 18.48 Mn |
| Sep 30, 2024 | 18.95 Mn |
| Jun 30, 2024 | 19.41 Mn |
| Mar 31, 2024 | 14.83 Mn |
| Dec 31, 2023 | 20.12 Mn |
| Sep 30, 2023 | 16.17 Mn |
| Jun 30, 2023 | 21.46 Mn |
| Mar 31, 2023 | 17.15 Mn |
| Dec 31, 2022 | 22.44 Mn |
| Sep 30, 2022 | 22.56 Mn |
| Jun 30, 2022 | 22.99 Mn |
| Mar 31, 2022 | 22.23 Mn |
| Dec 31, 2021 | 22.65 Mn |
| Sep 30, 2021 | 23.07 Mn |
| Jun 30, 2021 | 23.49 Mn |